ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Estrigenix Therapeutics raised $2 million in seed funding. The company focuses on developing treatments for menopause-related conditions. The funding round included participation from several investors.
Tap to vote and see what everyone thinks.
Summary by ByteBrief